Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00907426 · ClinicalTrials.gov registry record · Phase 3
Safety and Efficacy Study of Bimatoprost to Treat Hypotrichosis of the Eyelashes After Application to the Eyelid Margin
A Phase 3 study, sponsored by Allergan.
- Completed
- Registry status
- Phase 3
- Development phase
- 368
- Enrollment target
NCT00907426 is a Phase 3 study that has completed, run by Allergan. The registered enrollment target is 368 participants.
The verdict
NCT00907426, a Phase 3 study, has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 368 participants
- Enrollment target
Study Summary
This one-year study evaluates the long-term safety and effectiveness of bimatoprost solution application to the eyelid margin (where the eyelashes meet the skin) to treat hypotrichosis of the eyelashes (inadequate or not enough eyelashes). There will be two different types of subjects participating in the study 1)those with inadequate eyelashes due to natural causes or 2) those with inadequate eyelashes following a complete course of chemotherapy treatment. There will be two treatment periods of six months each. Subjects will receive either the study medication or vehicle in either of the two treatment periods.
Interventions
- DRUG Vehicle solution
- DRUG Bimatoprost 0.03% solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 368 participants |
| Start Date | 2009-08 |
| Est. Completion | 2011-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00907426
The ClinicalTrials.gov registry entry for NCT00907426 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 368 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allergan, which has 314 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vehicle solution is the first listed.
NCT00907426 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00907426 about?
NCT00907426 is a clinical study titled "Safety and Efficacy Study of Bimatoprost to Treat Hypotrichosis of the Eyelashes After Application to the Eyelid Margin". This one-year study evaluates the long-term safety and effectiveness of bimatoprost solution application to the eyelid margin (where the eyelashes meet the skin) to treat hypotrichosis of the eyelashes (inadequate or not enough eyelashes). There will be two different types of subjects participating ...
What is the current status of trial NCT00907426?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 368 participants. The study started on 2009-08. Estimated completion is 2011-05.
What interventions are being tested in trial NCT00907426?
The interventions under investigation include: Vehicle solution (DRUG), Bimatoprost 0.03% solution (DRUG).
Who is sponsoring clinical trial NCT00907426?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.